{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:18:41Z","timestamp":1791065921273,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond, Harboefonden","doi-asserted-by":"crossref","award":["FP7-HEALTH-F3-2009-241745"],"award-info":[{"award-number":["FP7-HEALTH-F3-2009-241745"]}],"id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ADITEC","award":["FP7-HEALTH-F2010-280873"],"award-info":[{"award-number":["FP7-HEALTH-F2010-280873"]}]},{"DOI":"10.13039\/100008617","name":"Danish National Advanced Technology Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008617","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007398","name":"Danish Council for Strategic Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007398","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.050","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T01:16:43Z","timestamp":1401239803000},"page":"3927-3935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant"],"prefix":"10.1016","volume":"32","author":[{"given":"Karen Smith","family":"Korsholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-5755","authenticated-orcid":false,"given":"Jon","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Filskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lindenstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Tandrup","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.05.050_bib0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ni1082","article-title":"Cellular mechanisms governing cross-presentation of exogenous antigens","volume":"5","author":"Ackerman","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0010","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Le Bon","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0020","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.143.5.1283","article-title":"Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay","volume":"143","author":"Bevan","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0025","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1004163","article-title":"Type I IFNs control antigen retention and survival of CD8\u03b1+ dendritic cells after uptake of tumor apoptotic cells leading to cross-priming","volume":"186","author":"Lorenzi","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0030","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2011-06-363564","article-title":"IFN-\u03b1 enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing","volume":"119","author":"Spadaro","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejps.2011.08.016","article-title":"License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems","volume":"45","author":"Foged","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0040","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.4049\/jimmunol.1004036","article-title":"A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity","volume":"186","author":"Fujimoto","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/eji.200323797","article-title":"Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8\u03b1+ DC correlates with unresponsiveness to imidazoquinolines","volume":"33","author":"Edwards","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0050","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.4049\/jimmunol.1102144","article-title":"Antimicrobial peptides inhibit polyinosinic\u2013polycytidylic acid-induced immune responses","volume":"187","author":"Hasan","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0055","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI39293","article-title":"Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice","volume":"120","author":"Zhu","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-011-1156-6","article-title":"CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice","volume":"61","author":"Hansen","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jconrel.2010.11.021","article-title":"Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method","volume":"150","author":"Nordly","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.182.1.424","article-title":"A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity","volume":"182","author":"Andersen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0080","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.4049\/jimmunol.0804091","article-title":"Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guerin","volume":"183","author":"Andersen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0085","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.bmcl.2009.02.027","article-title":"Adjuvant properties of a simplified C32 monomycolyl glycerol analogue","volume":"19","author":"Bhowruth","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpb.2010.10.001","article-title":"Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo","volume":"77","author":"Nordly","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0095","doi-asserted-by":"crossref","first-page":"20673","DOI":"10.1039\/C3RA42737D","article-title":"The supramolecular structure is decisive for the immunostimulatory properties of synthetic analogues of a mycobacterial lipid in vitro","volume":"3","author":"Martin-Bertelsen","year":"2013","journal-title":"RSC Adv"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6\u2032-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"Davidsen","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0105","doi-asserted-by":"crossref","first-page":"e63575","DOI":"10.1371\/journal.pone.0063575","article-title":"Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2\/DR transgenic mice with overlapping peptides in the CAF05 adjuvant","volume":"8","author":"Korsholm","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0115","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2012.12.005","article-title":"Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infection","volume":"146","author":"Karlsson","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0130","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.1073\/pnas.1104588108","article-title":"Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells","volume":"108","author":"MacLeod","year":"2011","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/vim.2007.0101","article-title":"Effective induction of type 1 helper IgG2a and cytotoxic T-cell responses in mice following immunization with human papillomavirus type 16 E2 in MF59","volume":"21","author":"Heinemann","year":"2008","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0140","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","article-title":"Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines","volume":"72","author":"Holten-Andersen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0145","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0150","doi-asserted-by":"crossref","first-page":"e53531","DOI":"10.1371\/journal.pone.0053531","article-title":"The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling","volume":"8","author":"Desel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0155","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.169.8.4222","article-title":"Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes","volume":"169","author":"Shen","year":"2002","journal-title":"J Immunol"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2014.05.050_bib0160","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/0022-1317-74-11-2507","article-title":"Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB","volume":"74","author":"Berencsi","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0165","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.77.16.8729-8735.2003","article-title":"Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines","volume":"77","author":"Barouch","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0170","doi-asserted-by":"crossref","first-page":"e5139","DOI":"10.1371\/journal.pone.0005139","article-title":"CD4 and CD8T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination","volume":"4","author":"Elvang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0175","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/eji.200425599","article-title":"Direct intralymphatic injection of peptide vaccines enhances immunogenicity","volume":"35","author":"Johansen","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2010.05.019","article-title":"Lympho-geographical concepts in vaccine delivery","volume":"148","author":"Johansen","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0185","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.4049\/jimmunol.181.6.4363","article-title":"Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells","volume":"181","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.05.050_bib0190","first-page":"1165","article-title":"Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice","volume":"118","author":"Liu","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2014.05.050_bib1234","article-title":"High-frequency vaccine-promoted CD8 T cells specific for an epitope naturally processed during infection with M. tuberculosis do not confer protection","author":"Lindenstr\u00f8m","year":"2014","journal-title":"EJI"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T23:54:55Z","timestamp":1589241295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14007269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":39,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14007269"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}